Brief: Theravance Biopharma Q2 Operating Income USD -15.705 Million
05/08/2024 21:05
Aug 05 (Reuters) - Theravance Biopharma Q2 adjusted net income USD -6.25 million vs. IBES estimate USD -9.99 million. * Q2 net income USD -16.529 million
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy